purchase customization

1 Study Coverage
1.1 Autoimmune Disorder Drug Delivery Device Product Introduction
1.2 Market by Type
1.2.1 Global Autoimmune Disorder Drug Delivery Device Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Pen Injectors
1.2.3 Auto-Injectors
1.2.4 Prefilled Syringes
1.2.5 Vials
1.3 Market by Application
1.3.1 Global Autoimmune Disorder Drug Delivery Device Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 In-house Manufacturing
1.3.3 Outsourced Manufacturing
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Autoimmune Disorder Drug Delivery Device Sales Estimates and Forecasts 2017-2028
2.2 Global Autoimmune Disorder Drug Delivery Device Revenue Estimates and Forecasts 2017-2028
2.3 Global Autoimmune Disorder Drug Delivery Device Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Autoimmune Disorder Drug Delivery Device Sales by Region
2.4.1 Global Autoimmune Disorder Drug Delivery Device Sales by Region (2017-2022)
2.4.2 Global Sales Autoimmune Disorder Drug Delivery Device by Region (2023-2028)
2.5 Global Autoimmune Disorder Drug Delivery Device Revenue by Region
2.5.1 Global Autoimmune Disorder Drug Delivery Device Revenue by Region (2017-2022)
2.5.2 Global Autoimmune Disorder Drug Delivery Device Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Autoimmune Disorder Drug Delivery Device Sales by Manufacturers
3.1.1 Global Top Autoimmune Disorder Drug Delivery Device Manufacturers by Sales (2017-2022)
3.1.2 Global Autoimmune Disorder Drug Delivery Device Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Autoimmune Disorder Drug Delivery Device in 2021
3.2 Global Autoimmune Disorder Drug Delivery Device Revenue by Manufacturers
3.2.1 Global Autoimmune Disorder Drug Delivery Device Revenue by Manufacturers (2017-2022)
3.2.2 Global Autoimmune Disorder Drug Delivery Device Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Autoimmune Disorder Drug Delivery Device Revenue in 2021
3.3 Global Autoimmune Disorder Drug Delivery Device Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Autoimmune Disorder Drug Delivery Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Autoimmune Disorder Drug Delivery Device Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Autoimmune Disorder Drug Delivery Device Sales by Type
4.1.1 Global Autoimmune Disorder Drug Delivery Device Historical Sales by Type (2017-2022)
4.1.2 Global Autoimmune Disorder Drug Delivery Device Forecasted Sales by Type (2023-2028)
4.1.3 Global Autoimmune Disorder Drug Delivery Device Sales Market Share by Type (2017-2028)
4.2 Global Autoimmune Disorder Drug Delivery Device Revenue by Type
4.2.1 Global Autoimmune Disorder Drug Delivery Device Historical Revenue by Type (2017-2022)
4.2.2 Global Autoimmune Disorder Drug Delivery Device Forecasted Revenue by Type (2023-2028)
4.2.3 Global Autoimmune Disorder Drug Delivery Device Revenue Market Share by Type (2017-2028)
4.3 Global Autoimmune Disorder Drug Delivery Device Price by Type
4.3.1 Global Autoimmune Disorder Drug Delivery Device Price by Type (2017-2022)
4.3.2 Global Autoimmune Disorder Drug Delivery Device Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Autoimmune Disorder Drug Delivery Device Sales by Application
5.1.1 Global Autoimmune Disorder Drug Delivery Device Historical Sales by Application (2017-2022)
5.1.2 Global Autoimmune Disorder Drug Delivery Device Forecasted Sales by Application (2023-2028)
5.1.3 Global Autoimmune Disorder Drug Delivery Device Sales Market Share by Application (2017-2028)
5.2 Global Autoimmune Disorder Drug Delivery Device Revenue by Application
5.2.1 Global Autoimmune Disorder Drug Delivery Device Historical Revenue by Application (2017-2022)
5.2.2 Global Autoimmune Disorder Drug Delivery Device Forecasted Revenue by Application (2023-2028)
5.2.3 Global Autoimmune Disorder Drug Delivery Device Revenue Market Share by Application (2017-2028)
5.3 Global Autoimmune Disorder Drug Delivery Device Price by Application
5.3.1 Global Autoimmune Disorder Drug Delivery Device Price by Application (2017-2022)
5.3.2 Global Autoimmune Disorder Drug Delivery Device Price Forecast by Application (2023-2028)
6 North America
6.1 North America Autoimmune Disorder Drug Delivery Device Market Size by Type
6.1.1 North America Autoimmune Disorder Drug Delivery Device Sales by Type (2017-2028)
6.1.2 North America Autoimmune Disorder Drug Delivery Device Revenue by Type (2017-2028)
6.2 North America Autoimmune Disorder Drug Delivery Device Market Size by Application
6.2.1 North America Autoimmune Disorder Drug Delivery Device Sales by Application (2017-2028)
6.2.2 North America Autoimmune Disorder Drug Delivery Device Revenue by Application (2017-2028)
6.3 North America Autoimmune Disorder Drug Delivery Device Market Size by Country
6.3.1 North America Autoimmune Disorder Drug Delivery Device Sales by Country (2017-2028)
6.3.2 North America Autoimmune Disorder Drug Delivery Device Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Autoimmune Disorder Drug Delivery Device Market Size by Type
7.1.1 Europe Autoimmune Disorder Drug Delivery Device Sales by Type (2017-2028)
7.1.2 Europe Autoimmune Disorder Drug Delivery Device Revenue by Type (2017-2028)
7.2 Europe Autoimmune Disorder Drug Delivery Device Market Size by Application
7.2.1 Europe Autoimmune Disorder Drug Delivery Device Sales by Application (2017-2028)
7.2.2 Europe Autoimmune Disorder Drug Delivery Device Revenue by Application (2017-2028)
7.3 Europe Autoimmune Disorder Drug Delivery Device Market Size by Country
7.3.1 Europe Autoimmune Disorder Drug Delivery Device Sales by Country (2017-2028)
7.3.2 Europe Autoimmune Disorder Drug Delivery Device Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Autoimmune Disorder Drug Delivery Device Market Size by Type
8.1.1 Asia Pacific Autoimmune Disorder Drug Delivery Device Sales by Type (2017-2028)
8.1.2 Asia Pacific Autoimmune Disorder Drug Delivery Device Revenue by Type (2017-2028)
8.2 Asia Pacific Autoimmune Disorder Drug Delivery Device Market Size by Application
8.2.1 Asia Pacific Autoimmune Disorder Drug Delivery Device Sales by Application (2017-2028)
8.2.2 Asia Pacific Autoimmune Disorder Drug Delivery Device Revenue by Application (2017-2028)
8.3 Asia Pacific Autoimmune Disorder Drug Delivery Device Market Size by Region
8.3.1 Asia Pacific Autoimmune Disorder Drug Delivery Device Sales by Region (2017-2028)
8.3.2 Asia Pacific Autoimmune Disorder Drug Delivery Device Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Autoimmune Disorder Drug Delivery Device Market Size by Type
9.1.1 Latin America Autoimmune Disorder Drug Delivery Device Sales by Type (2017-2028)
9.1.2 Latin America Autoimmune Disorder Drug Delivery Device Revenue by Type (2017-2028)
9.2 Latin America Autoimmune Disorder Drug Delivery Device Market Size by Application
9.2.1 Latin America Autoimmune Disorder Drug Delivery Device Sales by Application (2017-2028)
9.2.2 Latin America Autoimmune Disorder Drug Delivery Device Revenue by Application (2017-2028)
9.3 Latin America Autoimmune Disorder Drug Delivery Device Market Size by Country
9.3.1 Latin America Autoimmune Disorder Drug Delivery Device Sales by Country (2017-2028)
9.3.2 Latin America Autoimmune Disorder Drug Delivery Device Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Autoimmune Disorder Drug Delivery Device Market Size by Type
10.1.1 Middle East and Africa Autoimmune Disorder Drug Delivery Device Sales by Type (2017-2028)
10.1.2 Middle East and Africa Autoimmune Disorder Drug Delivery Device Revenue by Type (2017-2028)
10.2 Middle East and Africa Autoimmune Disorder Drug Delivery Device Market Size by Application
10.2.1 Middle East and Africa Autoimmune Disorder Drug Delivery Device Sales by Application (2017-2028)
10.2.2 Middle East and Africa Autoimmune Disorder Drug Delivery Device Revenue by Application (2017-2028)
10.3 Middle East and Africa Autoimmune Disorder Drug Delivery Device Market Size by Country
10.3.1 Middle East and Africa Autoimmune Disorder Drug Delivery Device Sales by Country (2017-2028)
10.3.2 Middle East and Africa Autoimmune Disorder Drug Delivery Device Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 AbbVie Inc.
11.1.1 AbbVie Inc. Corporation Information
11.1.2 AbbVie Inc. Overview
11.1.3 AbbVie Inc. Autoimmune Disorder Drug Delivery Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 AbbVie Inc. Autoimmune Disorder Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 AbbVie Inc. Recent Developments
11.2 Amgen Inc.
11.2.1 Amgen Inc. Corporation Information
11.2.2 Amgen Inc. Overview
11.2.3 Amgen Inc. Autoimmune Disorder Drug Delivery Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Amgen Inc. Autoimmune Disorder Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Amgen Inc. Recent Developments
11.3 F. Hoffmann- La Roche Ltd.
11.3.1 F. Hoffmann- La Roche Ltd. Corporation Information
11.3.2 F. Hoffmann- La Roche Ltd. Overview
11.3.3 F. Hoffmann- La Roche Ltd. Autoimmune Disorder Drug Delivery Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 F. Hoffmann- La Roche Ltd. Autoimmune Disorder Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 F. Hoffmann- La Roche Ltd. Recent Developments
11.4 Novartis AG
11.4.1 Novartis AG Corporation Information
11.4.2 Novartis AG Overview
11.4.3 Novartis AG Autoimmune Disorder Drug Delivery Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Novartis AG Autoimmune Disorder Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Novartis AG Recent Developments
11.5 GlaxoSmithKline Plc
11.5.1 GlaxoSmithKline Plc Corporation Information
11.5.2 GlaxoSmithKline Plc Overview
11.5.3 GlaxoSmithKline Plc Autoimmune Disorder Drug Delivery Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 GlaxoSmithKline Plc Autoimmune Disorder Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 GlaxoSmithKline Plc Recent Developments
11.6 Biogen Inc.
11.6.1 Biogen Inc. Corporation Information
11.6.2 Biogen Inc. Overview
11.6.3 Biogen Inc. Autoimmune Disorder Drug Delivery Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Biogen Inc. Autoimmune Disorder Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Biogen Inc. Recent Developments
11.7 Merck KGaA
11.7.1 Merck KGaA Corporation Information
11.7.2 Merck KGaA Overview
11.7.3 Merck KGaA Autoimmune Disorder Drug Delivery Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Merck KGaA Autoimmune Disorder Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Merck KGaA Recent Developments
11.8 Bayer AG
11.8.1 Bayer AG Corporation Information
11.8.2 Bayer AG Overview
11.8.3 Bayer AG Autoimmune Disorder Drug Delivery Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Bayer AG Autoimmune Disorder Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Bayer AG Recent Developments
11.9 Johnson & Johnson Services Inc.
11.9.1 Johnson & Johnson Services Inc. Corporation Information
11.9.2 Johnson & Johnson Services Inc. Overview
11.9.3 Johnson & Johnson Services Inc. Autoimmune Disorder Drug Delivery Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Johnson & Johnson Services Inc. Autoimmune Disorder Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Johnson & Johnson Services Inc. Recent Developments
11.10 Teva Pharmaceutical Industries Ltd.
11.10.1 Teva Pharmaceutical Industries Ltd. Corporation Information
11.10.2 Teva Pharmaceutical Industries Ltd. Overview
11.10.3 Teva Pharmaceutical Industries Ltd. Autoimmune Disorder Drug Delivery Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Teva Pharmaceutical Industries Ltd. Autoimmune Disorder Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Teva Pharmaceutical Industries Ltd. Recent Developments
11.11 Eli Lily and Company
11.11.1 Eli Lily and Company Corporation Information
11.11.2 Eli Lily and Company Overview
11.11.3 Eli Lily and Company Autoimmune Disorder Drug Delivery Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Eli Lily and Company Autoimmune Disorder Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Eli Lily and Company Recent Developments
11.12 Sanofi S.A.
11.12.1 Sanofi S.A. Corporation Information
11.12.2 Sanofi S.A. Overview
11.12.3 Sanofi S.A. Autoimmune Disorder Drug Delivery Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Sanofi S.A. Autoimmune Disorder Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Sanofi S.A. Recent Developments
11.13 Takeda Pharmaceutical Company Limited
11.13.1 Takeda Pharmaceutical Company Limited Corporation Information
11.13.2 Takeda Pharmaceutical Company Limited Overview
11.13.3 Takeda Pharmaceutical Company Limited Autoimmune Disorder Drug Delivery Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Takeda Pharmaceutical Company Limited Autoimmune Disorder Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Takeda Pharmaceutical Company Limited Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Autoimmune Disorder Drug Delivery Device Industry Chain Analysis
12.2 Autoimmune Disorder Drug Delivery Device Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Autoimmune Disorder Drug Delivery Device Production Mode & Process
12.4 Autoimmune Disorder Drug Delivery Device Sales and Marketing
12.4.1 Autoimmune Disorder Drug Delivery Device Sales Channels
12.4.2 Autoimmune Disorder Drug Delivery Device Distributors
12.5 Autoimmune Disorder Drug Delivery Device Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Autoimmune Disorder Drug Delivery Device Industry Trends
13.2 Autoimmune Disorder Drug Delivery Device Market Drivers
13.3 Autoimmune Disorder Drug Delivery Device Market Challenges
13.4 Autoimmune Disorder Drug Delivery Device Market Restraints
14 Key Findings in The Global Autoimmune Disorder Drug Delivery Device Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer